medline.ch Onkologie Urologische Tumoren

	Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study. Urology Kim IE Jr, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK, Keith SW, Kim IY, Lu-Yao G. PMID: 42551541 [PubMed - as supplied by publisher]
	Urinary incontinence after treatment for localized prostate cancer: A systematic review and meta-analysis. Actas Urol Esp (Engl Ed) Amaris Vanegas AP, Cabrera Díaz DC, Salgar Prada JD, Sánchez Moreno JV, Gómez Rodríguez DP. PMID: 42551523 [PubMed - as supplied by publisher]
	Imaging modalities in advanced prostate cancer: interim analysis of the Spanish cohort of the RING registry. Actas Urol Esp (Engl Ed) Chernysheva D, Gómez Gómez E, Burgos Revilla J, Fernández Conejo G, García Barreras S, Linares Espinós E, Gómez Villanueva A, Domínguez Esteban M, Mera Errasti A, Breda A, Fanti S, Bjartell A, Padhani AR, Sanguedolce F. PMID: 42551522 [PubMed - as supplied by publisher]
	Effectiveness and Safety of Hormonal Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter Real-World Study. Actas Urol Esp (Engl Ed) Guedes Oliva P, Pérez-Fentes D, De Pablos-Rodríguez P, Bardella-Altarriba C, Díaz-Pedrouzo A, Abuin-García J, Vera-Ballesteros FJ, Abella-Serra A, Ribera-Díaz D, Martínez-Corral ME, Gómez-Ferrer Á, Picola-Brau N, Martínez-Breijo S, Costa-Planells M, López-Abad A, García-Puche M, Jiménez Marrero P, Martínez Corral R. PMID: 42551521 [PubMed - as supplied by publisher]
	Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57. Eur Urol Luca S, Ferrando L, Porpiglia F. PMID: 42552153 [PubMed - as supplied by publisher]
	Beyond the Trial: Can Audit and Feedback Produce Lasting Improvements in Transurethral Resection of Bladder Tumor Quality? Fr J Urol Mercier J, de la Taille A, Vordos D, Duquesne I. PMID: 42551555 [PubMed - as supplied by publisher]
	Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations. Clin Adv Hematol Oncol Lee MS, Shi CT, Kim TH, Morales Martinez GA, Vasdev R, Waddle M, Takahashi N, Boorjian SA, Khanna A. PMID: 42550814 [PubMed - indexed for MEDLINE]
	Deep learning-based prostate cancer diagnosis on MRI with hip prostheses: artifact and sequence effects. Abdom Radiol (NY) Nakai H, Kurata Y, Takahashi H, Adamo D, Froemming A, LeGout J, Kawashima A, Cai J, Kido A, Kuanar S, Gloe J, Borisch E, Riederer S, Khanna A, Takahashi N. PMID: 42550188 [PubMed - as supplied by publisher]
	Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS, AREN03B2 study committee. PMID: 42549996 [PubMed - as supplied by publisher]
	Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort. Diabetes Metab Res Rev Choi M, Heo SJ, Kwon YJ, Kang CM. PMID: 42549759 [PubMed - indexed for MEDLINE]
	Clinical-imaging fusion model for risk assessment of clinically significant prostate cancer. Front Oncol Chen Y, Yu Z, Xu J, Kang X, Liang L, He J, Li Y, Hu Q, Feng B, Liu P. PMID: 42548646 [PubMed]
	Feasibility of opportunistic bone health assessment using low-dose CT trabecular attenuation and (18)F-NaF uptake from PET/CT in prostate cancer. Front Endocrinol (Lausanne) Liu C, Liang F, Li Z, Wang Z, Fu W, Mu X. PMID: 42548567 [PubMed - indexed for MEDLINE]
	Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1. Kidney Res Clin Pract Petrovic V, Malkov VA, Billin AN, Patel UD, Pergola PE, Chertow GM, Skupien J, Krolewski AS. PMID: 42548168 [PubMed - as supplied by publisher]
	Image-based evaluation of a commercial AI synthetic CT generator for brain and prostate MR-only radiotherapy. J Appl Clin Med Phys Aire M, Matthews C, Jones J, Duong D, Schneider C, Stathakis S, Shay O, Kirby K. PMID: 42547906 [PubMed - indexed for MEDLINE]
	Artificial intelligence empowers full-stack histopathological diagnosis and prognosis of renal cell tumor: a multi-center study with external validation. BMC Med Xiong Y, Xi W, Zhang G, Luo X, Xiao L, Gao J, Wang R, Wang K, Zhao Y, Sun Q, Wang Z, Guo J, Qu L, Hou Y, Zhao D, Wang S. PMID: 42547870 [PubMed - indexed for MEDLINE]
	Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations. Prostate Cancer Prostatic Dis Ditonno F, Veccia A, Bernardino RM, Brunelli M, Cindolo L, Ferrari G, Falagario U, Nguyen JK, Autorino R, Bertolo R, Antonelli A. PMID: 42547539 [PubMed - as supplied by publisher]
	Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancer. Urol Oncol Paras G, Schweizer MT. PMID: 42547387 [PubMed - as supplied by publisher]
	Prognostic value of different biomarkers in bladder cancer: protocol for an umbrella review of systematic reviews and meta-analyses. BMJ Open Aghamir SMK, Rahimnia R, Taheri D, Ebrahimi M, Talebian MT, Keshtkar A, Ghasemi M, Mohammadi SD, Menbari Oskouie I, Nikoofar P, Khatami F. PMID: 42547229 [PubMed - indexed for MEDLINE]
	Contemporary Updates on Subtypes of Prostate Cancer. Arch Pathol Lab Med Jia L, Yang XJ. PMID: 42547080 [PubMed - as supplied by publisher]
	Radiotherapy strategies for prostate cancer: Techniques, outcomes, and patient care. Cancer Treat Res Commun Khalaji A, Ghazi F, Alivirdiloo V, Abosaoda MK, Kashyap A, T S, Ray S, Sharma A, Mobed A. PMID: 42546529 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 180498

Seite 1 von 9025

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung